Elos Medtech acquires Klingel Medical

On July 28, 2023, Elos Medtech AB (publ), a leading development and manufacturing partner for medical devices, announced that it has entered into an agreement to acquire Klingel Holding GmbH (Klingel) from IK Partners and management. The purchase price corresponds to an enterprise value of EUR 370 million. The completion of the transaction is subject to customary regulatory approvals, acceptance at the extraordinary general meeting and successful completion of a rights issue to finance the acquisition. The rights issue will be guaranteed through the subscription and guarantee undertaking of TA Associates, through EM Intressenter AB, ElosMedtech’s principal shareholder. Closing is expected to take place in the fourth quarter of 2023.

Lenz & Staehelin advises Elos Medtech in this transaction. The team is led by Simone Ehrsam and Tino Gaberthüel (both Corporate/M&A) and includes Xavier Grivel, Lukas Staub and Dominik Mann (all Corporate/M&A), Beat Kühni and Cécile Moser (both Real Estate), Elena Nauer (Employment/Pension) and Peter Ling (IP).